Who is the CEO of Kineta, Inc.?

The CEO of Kineta, Inc. is Craig W. Philips.

What industry does Kineta, Inc. belong to?

Kineta, Inc. operates in the Biotechnology industry within the Healthcare sector.

Where is Kineta, Inc. headquartered?

Kineta, Inc. is headquartered at 219 Terry Ave. N, Seattle, WA, 98109, US.

What is the IPO date of Kineta, Inc.?

Kineta, Inc. went public on February 11, 2016.

How many employees does Kineta, Inc. have?

Kineta, Inc. has approximately 11 full-time employees.

Kineta, Inc.

KA•NASDAQ

Healthcare

Biotechnology

$0.57

$-0.26(-30.77%)

Kineta, Inc. (KA) Company Profile & Overview

Explore Kineta, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Kineta, Inc. (KA) Company Profile & Overview

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.

SectorHealthcare

IndustryBiotechnology

CEOCraig W. Philips

Contact Information

https://kinetabio.com

206 378 0400

219 Terry Ave. N, Seattle, WA, 98109

Company Facts

11 Employees

IPO DateFeb 11, 2016

CountryUS

Frequently Asked Questions

;